These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 17785330

  • 1. Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies.
    Gomard-Mennesson E, Fabien N, Cordier JF, Ninet J, Tebib J, Rousset H.
    Ann N Y Acad Sci; 2007 Aug; 1109():414-20. PubMed ID: 17785330
    [Abstract] [Full Text] [Related]

  • 2. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [Abstract] [Full Text] [Related]

  • 3. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.
    Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF, Levesque H, Jouen F.
    Semin Arthritis Rheum; 2012 Jun; 41(6):890-9. PubMed ID: 22078416
    [Abstract] [Full Text] [Related]

  • 4. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
    Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP, Vittecoq O, Noel D, Mouthon L, Menard JF, Jouen F.
    Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
    [Abstract] [Full Text] [Related]

  • 5. Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome.
    Legault D, McDermott J, Crous-Tsanaclis AM, Boire G.
    J Rheumatol; 2008 Jan; 35(1):169-71. PubMed ID: 18176990
    [Abstract] [Full Text] [Related]

  • 6. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
    Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B, Nunes H, Maisonobe T, Olsson NO, Adoue D, Arlet P, Sibilia J, Guiguet M, Lauque D, Amoura Z, Hachulla E, Hamidou M, Benveniste O.
    Autoimmun Rev; 2012 Dec; 12(2):210-7. PubMed ID: 22771754
    [Abstract] [Full Text] [Related]

  • 7. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV.
    Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
    [Abstract] [Full Text] [Related]

  • 8. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
    Ramos-Casals M, Nardi N, Brito-Zerón P, Aguiló S, Gil V, Delgado G, Bové A, Font J.
    Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
    [Abstract] [Full Text] [Related]

  • 9. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.
    Sato S, Kuwana M, Hirakata M.
    Rheumatology (Oxford); 2007 May; 46(5):842-5. PubMed ID: 17255133
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome.
    Notarnicola A, Preger C, Lundström SL, Renard N, Wigren E, Van Gompel E, Galindo-Feria AS, Persson H, Fathi M, Grunewald J, Jakobsson PJ, Gräslund S, Lundberg IE, Fernandes-Cerqueira C.
    Arthritis Res Ther; 2022 Mar 02; 24(1):62. PubMed ID: 35236390
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases.
    Frikha F, Rigolet A, Behin A, Fautrel B, Herson S, Benveniste O.
    Rheumatology (Oxford); 2009 Sep 02; 48(9):1166-8. PubMed ID: 19549788
    [No Abstract] [Full Text] [Related]

  • 12. Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies.
    Fernandes-Cerqueira C, Renard N, Notarnicola A, Wigren E, Gräslund S, Zubarev RA, Lundberg IE, Lundström SL.
    Sci Rep; 2018 Dec 18; 8(1):17958. PubMed ID: 30560888
    [Abstract] [Full Text] [Related]

  • 13. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia.
    Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N.
    Rheumatology (Oxford); 2007 Jun 18; 46(6):1005-8. PubMed ID: 17392287
    [Abstract] [Full Text] [Related]

  • 14. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T, Imura Y, Nakashima R, Yoshifuji H.
    Curr Opin Rheumatol; 2007 Nov 18; 19(6):523-9. PubMed ID: 17917530
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
    Ghillani P, André C, Toly C, Rouquette AM, Bengoufa D, Nicaise P, Goulvestre C, Gleizes A, Dragon-Durey MA, Alyanakian MA, Chretien P, Chollet-Martin S, Musset L, Weill B, Johanet C.
    Autoimmun Rev; 2011 Jul 18; 10(9):509-13. PubMed ID: 21447407
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).
    Rojas-Serrano J, Herrera-Bringas D, Mejía M, Rivero H, Mateos-Toledo H, Figueroa JE.
    Clin Rheumatol; 2015 Sep 18; 34(9):1563-9. PubMed ID: 26219488
    [Abstract] [Full Text] [Related]

  • 17. Retinal vasculitis associated with the anti-synthetase syndrome.
    Tarabishy AB, Khan M, Bunyard M, Lowder CY.
    Ocul Immunol Inflamm; 2010 Jan 18; 18(1):16-8. PubMed ID: 20128644
    [Abstract] [Full Text] [Related]

  • 18. [Analytic study of dot blotting for the detection of anti-Jo-1, anti-M2, anti-ribosomes and anti-LKM].
    Huguet S, Sghiri R, Ballot E, Johanet C.
    Ann Biol Clin (Paris); 2004 Jan 18; 62(4):423-9. PubMed ID: 15297236
    [Abstract] [Full Text] [Related]

  • 19. Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome.
    Yamaguchi K, Tang Q, Poland P, Reay DP, Gregory A, Aggarwal R, Oddis CV, Ascherman DP.
    Front Immunol; 2024 Jan 18; 15():1399451. PubMed ID: 38895121
    [Abstract] [Full Text] [Related]

  • 20. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease.
    Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, Akizuki M, Targoff IN.
    J Immunol; 1999 Feb 15; 162(4):2315-20. PubMed ID: 9973509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.